216 related articles for article (PubMed ID: 37371715)
1. Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases.
Dara P; Farooqui Z; Mwale F; Choe C; van Wijnen AJ; Im HJ
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371715
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.
Trofimovitch D; Baumrucker SJ
Am J Hosp Palliat Care; 2019 Oct; 36(10):907-912. PubMed ID: 30917675
[TBL] [Abstract][Full Text] [Related]
3. The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
Patten DK; Schultz BG; Berlau DJ
Pharmacotherapy; 2018 Mar; 38(3):382-389. PubMed ID: 29377216
[TBL] [Abstract][Full Text] [Related]
4. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
Kim PS; Fishman MA
Curr Pain Headache Rep; 2020 Aug; 24(10):64. PubMed ID: 32845365
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.
Toljan K; Vrooman B
Med Sci (Basel); 2018 Sep; 6(4):. PubMed ID: 30248938
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose Naltrexone in Rheumatological Diseases.
de Carvalho JF; Skare T
Mediterr J Rheumatol; 2023 Mar; 34(1):1-6. PubMed ID: 37223594
[TBL] [Abstract][Full Text] [Related]
7. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Younger J; Parkitny L; McLain D
Clin Rheumatol; 2014 Apr; 33(4):451-9. PubMed ID: 24526250
[TBL] [Abstract][Full Text] [Related]
8. Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.
Raknes G; Småbrekke L
Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):685-693. PubMed ID: 28370746
[TBL] [Abstract][Full Text] [Related]
9. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
[TBL] [Abstract][Full Text] [Related]
10. Pilot Study of Low-dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-controlled, Crossover Clinical Trial.
Beaudette-Zlatanova B; Lew RA; Otis JD; Branch-Elliman W; Bacorro E; Dubreuil M; Eyvazzadeh C; Kaur M; Lazzari AA; Libbey C; Monach PA
Clin Ther; 2023 May; 45(5):468-477. PubMed ID: 37045708
[TBL] [Abstract][Full Text] [Related]
11. Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study.
Martin SJ; McAnally HB; Okediji P; Rogosnitzky M
Pain Manag; 2022 Sep; 12(6):699-709. PubMed ID: 35289682
[TBL] [Abstract][Full Text] [Related]
12. Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.
Katz N; Hale M; Morris D; Stauffer J
Postgrad Med; 2010 Jul; 122(4):112-28. PubMed ID: 20675975
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
Oaks Z; Stage A; Middleton B; Faraone S; Johnson B
Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Low Dose Naltrexone for Chronic Pain.
N Irwin M; A Cooke D; Berland D; D Marshall V; A Smith M
J Pain Palliat Care Pharmacother; 2024 Mar; 38(1):13-19. PubMed ID: 38301136
[TBL] [Abstract][Full Text] [Related]
15. Low-dose naltrexone's utility for non-cancer centralized pain conditions: a scoping review.
Rupp A; Young E; Chadwick AL
Pain Med; 2023 Nov; 24(11):1270-1281. PubMed ID: 37302106
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the opioid mu receptor based pharmacotherapy for rheumatoid arthritis.
Pelechas E; Voulgari PV; Drosos AA
Expert Opin Pharmacother; 2020 Dec; 21(17):2153-2160. PubMed ID: 33135514
[TBL] [Abstract][Full Text] [Related]
18. Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review.
Soin A; Soin Y; Dann T; Buenaventura R; Ferguson K; Atluri S; Sachdeva H; Sudarshan G; Akbik H; Italiano J
Pain Physician; 2021 Jul; 24(4):E393-E406. PubMed ID: 34213865
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
